Limin Liu

Title: Limin Liu - Innovator in Pharmaceutical Chemistry

Introduction

Limin Liu is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of selective inhibitors for cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Limin Liu holds a patent for a trifluoromethyl-substituted sulfonamide as a BCL-2-selective inhibitor. This patent discloses a compound of formula I, along with its stereoisomers and pharmaceutically acceptable salts. The preparation method and pharmaceutical composition of this compound are also detailed in the patent. The compound is particularly useful for treating anti-apoptotic BCL-2-related diseases, such as cancer, highlighting its potential impact on cancer therapies.

Career Highlights

Limin Liu is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His career is marked by a commitment to research and development in the pharmaceutical industry, contributing to advancements that can improve patient outcomes.

Collaborations

Limin Liu collaborates with talented colleagues, including Fei Liu and Weiwei Feng. These partnerships enhance the research environment and foster innovation within their projects.

Conclusion

Limin Liu's contributions to pharmaceutical chemistry, particularly through his patented work, demonstrate his commitment to addressing critical health challenges. His innovative approach to developing selective inhibitors positions him as a key figure in the fight against cancer.